StonvexLoading…
StonvexStonvexStonvexCore line items from WES's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.07B | $1.12B | $3.84B | $2.81B | $1.86B |
Operating Income | Not available | $469.19M | $1.60B | $1.30B | $854.28M |
Net Income | Not available | $350.28M | $1.18B | $990.30M | $650.69M |
EPS (Diluted) | $0.84 | Not available | Not available | Not available | Not available |
Total Assets | Not available | $14.92B | $15.00B | $12.13B | $12.16B |
Total Liabilities | Not available | $11.42B | $10.84B | $8.80B | $8.83B |
Cash & Equivalents | Not available | $647.50M | $819.49M | $177.29M | $129.73M |
Free Cash Flow OCF − CapEx | Not available | $234.18M | $1.49B | $1.16B | $773.75M |
Shares Outstanding | Not available | Not available | Not available | Not available | Not available |